Novavax EVP R&D granted options and RSUs
Novavax, Inc. EVP of R&D Robert Edward Walker received new equity compensation awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Novavax, Inc. EVP of R&D Robert Edward Walker received new equity compensation awards. He was granted stock options covering 99,500 shares of common stock at an exercise price of $8.46 per share, expiring on April 14, 2036.
The option vests 25% on the first anniversary of the April 14, 2026 grant date, with the remaining 75% vesting in equal monthly installments over the following three years, subject to continued employment. He also received 66,000 restricted stock units, each representing one share of common stock, vesting in three equal annual installments over three years, also contingent on continued employment.
Insider Trade Summary
Grant/Award: 165,500 shares
Grant/Award
2 txns
Insider
Walker Robert Edward
Role
EVP, R&D
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 99,500 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 66,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 99,500 contracts (Direct);
Restricted Stock Units — 6,600 contracts (Direct)
Footnotes (3)
- F1. Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
- F2. Each RSU represents a contingent right to receive one share of the "Company" common stock.
- F3. The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the April 14, 2026 grant date, in each case subject to continued employment with the Company through such vesting date.
Key Figures
Stock options granted: 99,500 shares
Option exercise price: $8.46 per share
Option expiration: April 14, 2036
+4 more
7 metrics
Stock options granted
99,500 shares
Grant to EVP R&D on April 14, 2026
Option exercise price
$8.46 per share
Stock option grant strike price
Option expiration
April 14, 2036
Stock option expiry date
RSUs granted
66,000 units
Restricted Stock Units tied to common stock
Initial option vesting
25% after 1 year
First anniversary of grant date
Remaining option vesting
75% over 3 years
Equal monthly installments after first year
RSU vesting schedule
1/3 each year for 3 years
On each anniversary of April 14, 2026
Key Terms
Stock Option (Right to Buy), Restricted Stock Units, Amended and Restated 2015 Stock Incentive Plan, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Restricted Stock Units financial
"security_title: "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated 2015 Stock Incentive Plan financial
"granted under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan"
vesting financial
"vest on the first anniversary of the grant date, and the remaining"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
contingent right financial
"Each RSU represents a contingent right to receive one share"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Novavax (NVAX) grant to EVP R&D Robert Walker?
Novavax granted Robert Walker stock options for 99,500 shares at $8.46 per share and 66,000 restricted stock units. These awards provide long-term equity incentives tied to continued employment and future stock performance.
How do Robert Walker’s new Novavax stock options vest?
The 99,500 stock options vest 25% on the first anniversary of the April 14, 2026 grant date. The remaining 75% vest in equal monthly installments over the next three years, assuming he remains employed at Novavax.
What are the terms of the restricted stock units granted to Novavax EVP R&D?
Robert Walker received 66,000 restricted stock units, each representing one Novavax common share. These RSUs vest in three equal annual installments on each of the first three anniversaries of the April 14, 2026 grant date, subject to continued employment.
What is the exercise price and expiration date of Robert Walker’s Novavax options?
The granted stock options have an exercise price of $8.46 per share and expire on April 14, 2036. They become exercisable over four years as they vest, aligning his potential gains with Novavax’s long-term share performance.
Are Robert Walker’s Novavax equity awards tied to continued employment?
Yes. Both the stock options and restricted stock units require continued employment at Novavax to vest. If employment ends before scheduled vesting dates, unvested options and RSUs may be forfeited under the plan’s terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates